| GlaxoSmithKline Cutting Prices to Gain Market Share in China ChinaBio Today submits: Because GlaxoSmithKline (GSK) wants to double its China and India revenues by 2015, the company will significantly reduce its prices – as much as 70% – to raise revenues. The company readily admits it is trailing its multinational rivals such as Pfizer (PFE) and Sanofi-Aventis (SNY) in developing markets.Abbas Hussain, President of Emerging Markets for Glaxo, said in an interview with Bloomberg News:Complete Story » seekingalpha.com |
Fresh Effort to Counter Tourette Tics Researchers find behavioral therapy can help some patient manage urges. online.wsj.com |
Matrixx Initiatives, Inc. F1Q11 (Qtr End 06/30/10) Earnings Call Transcript Matrixx Initiatives, Inc. (MTXX)F1Q11 (Qtr End 06/30/10) Earnings Call TranscriptAugust 4, 2010 11:00 am ETComplete Story » seekingalpha.com |
Novartis Unit to Pay $422.5 Million in Marketing Case A U.S. subsidiary of Novartis has agreed to pay $422.5 million to resolve criminal and civil charges that it illegally marketed the epilepsy drug Trileptal and paid kickbacks to doctors. online.wsj.com |
CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at 'The Marijuana Conference' in New York City on Oct. 25 & 26 [PR Newswire] - Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the upcoming coverage by CNBC, Discovery Channel and National Geographic for the speaking engagement of Dr. us.rd.yahoo.com |